Analgesics Market Poised for Strong Growth, Expected to Reach USD 57 Million by 2030

Analgesics Market Poised for Strong Growth, Expected to Reach USD 57 Million by 2030

According to Next Move Strategy Consulting, the global Analgesics Market, is on track to reach USD 57 million by 2030, growing at a robust compound annual growth rate (CAGR) of 5%. This growth is primarily driven by the increasing prevalence of chronic diseases, the rising number of medical surgeries, and advancements in drug development.

Download Free Sample: https://www.nextmsc.com/analgesics-market/request-sample

Market Drivers

  1. Prevalence of Chronic Diseases and Infectious Conditions: The rising incidence of chronic diseases, such as heart diseases, stroke, chronic obstructive pulmonary disease (COPD), diabetes, and cancer, is significantly boosting the demand for pain-relieving medications. According to the World Health Organization (WHO), these chronic conditions were responsible for millions of deaths in 2021. In parallel, infectious diseases, including gastrointestinal, respiratory, and neurological conditions, are also contributing to the growing demand for analgesics worldwide.
  2. Increase in Surgical Procedures: A surge in surgeries, especially those involving the geriatric population and laparoscopic procedures, is another critical factor driving market growth. Optimal pain management during and after surgery is essential, which in turn increases the demand for analgesics. With patients increasingly seeking outpatient or at-home recovery options, the demand for effective and easily manageable pain relief solutions is expanding.
  3. Advancements in Drug Development: The development of new analgesics targeting specific pain pathways presents significant opportunities for market growth. Companies in the industry are investing heavily in research and development to create more effective, targeted treatments, particularly for conditions that are resistant to traditional analgesics.

Inquire Before Buying: https://www.nextmsc.com/analgesics-market/inquire-before-buying

Market Restraints

While the market is expected to experience significant growth, the evolving regulatory landscape poses challenges. Regulatory hurdles, particularly in the U.S. and Europe, are delaying product approvals and increasing the time and cost of bringing new analgesic drugs to market. The U.S. Food and Drug Administration (FDA) has implemented stricter guidelines for the approval of new medical devices and drugs, which may impede the timely launch of analgesic medications.

Regional Insights

  • North America: Currently, North America holds the largest share of the global analgesics market and is expected to continue leading throughout the forecast period. Factors such as a high prevalence of osteoarthritis, cardiovascular diseases, and cancer, coupled with a growing geriatric population, are driving the demand for analgesics in this region.
  • Asia-Pacific: The Asia-Pacific region is witnessing substantial growth due to increasing cases of arthritis, bone-related conditions, and diabetic neuropathy, all of which contribute to a higher demand for pain management solutions. Additionally, rising fever cases are driving the consumption of common analgesics like paracetamol.

Competitive Landscape

The global analgesics market is highly competitive, with key players such as Abbott Laboratories, Bayer AG, GlaxoSmithKline, Johnson & Johnson, Pfizer, Novartis, Teva Pharmaceuticals, Sanofi SA, AbbVie Inc., and Sun Pharmaceutical Industries leading the charge. These companies are focusing on strategic collaborations, acquisitions, and the development of novel analgesic solutions to maintain and expand their market presence.

For example, Pfizer Inc. acquired Biohaven Pharmaceutical Holding Company Ltd. in May 2022 to bolster its migraine treatment portfolio. Similarly, Novartis’ fast-track designation from the FDA for its osteoarthritis treatment, LNA043, underscores the growing focus on developing next-generation pain therapies.

Analgesics Market Key Segments

  • By Type: Non-Opioids, Opioids
  • By Route of Administration: Oral Route, Intravenous Route, Rectal Route, Transdermal Route, Topical Route
  • By Region: North America, Europe, Asia-Pacific, Rest of the World (RoW)

Conclusion

The global analgesics market is set for substantial growth, driven by the increasing prevalence of chronic diseases, a rising number of medical procedures, and advancements in pharmaceutical research. However, regulatory challenges may pose short-term obstacles. The market's future looks promising, with companies focusing on expanding their portfolios and developing innovative pain management solutions. North America will remain a dominant market, while the Asia-Pacific region shows significant growth potential.

Also, Browse Related Reports:   

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Back to blog